153 related articles for article (PubMed ID: 25792709)
21. miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway.
Zhang JJ; Chen JT; Hua L; Yao KH; Wang CY
Biomed Pharmacother; 2017 Jan; 85():472-478. PubMed ID: 27890434
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
Ye J; Li L; Feng P; Wan J; Li J
Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling.
Zhang Y; Wei W; Cheng N; Wang K; Li B; Jiang X; Sun S
Hepatology; 2012 Nov; 56(5):1631-40. PubMed ID: 22610915
[TBL] [Abstract][Full Text] [Related]
24. miR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway.
Xu X; Chen W; Miao R; Zhou Y; Wang Z; Zhang L; Wan Y; Dong Y; Qu K; Liu C
Oncotarget; 2015 Feb; 6(6):3988-4004. PubMed ID: 25686834
[TBL] [Abstract][Full Text] [Related]
25. miR-34a Inhibitor May Effectively Protect against Sevoflurane-Induced Hippocampal Apoptosis through the Wnt/β-Catenin Pathway by Targeting Wnt1.
Zhao X; Sun Y; Ding Y; Zhang J; Li K
Yonsei Med J; 2018 Dec; 59(10):1205-1213. PubMed ID: 30450855
[TBL] [Abstract][Full Text] [Related]
26. Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant β-catenin.
Tao J; Xu E; Zhao Y; Singh S; Li X; Couchy G; Chen X; Zucman-Rossi J; Chikina M; Monga SP
Hepatology; 2016 Nov; 64(5):1587-1605. PubMed ID: 27097116
[TBL] [Abstract][Full Text] [Related]
27. Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.
Harada N; Miyoshi H; Murai N; Oshima H; Tamai Y; Oshima M; Taketo MM
Cancer Res; 2002 Apr; 62(7):1971-7. PubMed ID: 11929813
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular carcinoma through suppression of WWOX.
Hua HW; Jiang F; Huang Q; Liao Z; Ding G
Oncotarget; 2015 Feb; 6(6):3840-7. PubMed ID: 25708809
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
31. The concomitant loss of APC and HNF4α in adult hepatocytes does not contribute to hepatocarcinogenesis driven by β-catenin activation.
Sartor C; Bachelot L; Godard C; Lager F; Renault G; Gonzalez FJ; Perret C; Gougelet A; Colnot S
Liver Int; 2019 Apr; 39(4):727-739. PubMed ID: 30721564
[TBL] [Abstract][Full Text] [Related]
32. miR-34a Inhibits Cell Proliferation by Targeting SATB2 in Hepatocellular Carcinoma.
Wu G; Li Z; Wang Y; Ju X; Huang R
Biomed Res Int; 2018; 2018():2863902. PubMed ID: 30627547
[TBL] [Abstract][Full Text] [Related]
33. The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling.
Ji Y; Wang M; Li X; Cui F
Yonsei Med J; 2019 Apr; 60(4):336-345. PubMed ID: 30900419
[TBL] [Abstract][Full Text] [Related]
34. Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice.
Braeuning A; Gavrilov A; Geissler M; Wenz C; Colnot S; Templin MF; Metzger U; Römer M; Zell A; Schwarz M
Arch Toxicol; 2016 Jun; 90(6):1481-94. PubMed ID: 26838046
[TBL] [Abstract][Full Text] [Related]
35. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
[TBL] [Abstract][Full Text] [Related]
36. 0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop.
Xia C; Shui L; Lou G; Ye B; Zhu W; Wang J; Wu S; Xu X; Mao L; Xu W; Chen Z; Liu Y; Zheng M
Sci Rep; 2017 Jun; 7(1):4396. PubMed ID: 28667294
[TBL] [Abstract][Full Text] [Related]
37.
Kastenhuber ER; Lalazar G; Houlihan SL; Tschaharganeh DF; Baslan T; Chen CC; Requena D; Tian S; Bosbach B; Wilkinson JE; Simon SM; Lowe SW
Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13076-13084. PubMed ID: 29162699
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis.
Gotoh J; Obata M; Yoshie M; Kasai S; Ogawa K
Carcinogenesis; 2003 Mar; 24(3):435-42. PubMed ID: 12663502
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-766 promotes cancer progression by targeting NR3C2 in hepatocellular carcinoma.
Yang C; Ma X; Guan G; Liu H; Yang Y; Niu Q; Wu Z; Jiang Y; Bian C; Zang Y; Zhuang L
FASEB J; 2019 Jan; 33(1):1456-1467. PubMed ID: 30130435
[TBL] [Abstract][Full Text] [Related]
40. The long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of β-catenin in HCC cells.
Cao C; Sun J; Zhang D; Guo X; Xie L; Li X; Wu D; Liu L
Gastroenterology; 2015 Feb; 148(2):415-26.e18. PubMed ID: 25449213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
